Our study reveals the critical role of miR-155 in the regulation of IL-10 production in B cells and demonstrates novel molecular mechanisms underlying the impaired number and function of B10 cells in CD patients, which will promote the development of B10 cell-based strategies to prevent disease progression in CD patients. This evidence concerns the gene IL10 and Cowden disease.